The transport of neuropeptides from central ganglia to components of the feeding system was studied in Aplysia. Peptide transport was determined by incubating buccal or cerebral ganglia with %-methionine and measuring the appearance of labeled peptides by high-pressure liquid chromatography (HPLC) of extracts of target tissues. Selected nerves were left intact and passed through a Vaseline diffusion barrier separating the ganglia and their targets. Five major labeled peptides were observed to be transported from the buccal ganglia to feeding muscles. They were buccalin, FMRFamide, myomodulin, and 2 small cardioactive peptides.
Each of these peptides has been shown to modulate the responses of these muscles to their motor neurons. The peptides were transported by fast axonal transport, as judged by the distance transported and the sensitivity to colchicine.
When normalized to correct for differences in total incorporation, the patterns of peptide transport were reproducible between animals. The nature and amount of the peptides transported were different for different muscles. The nature of peptide transport also varied for different nerve groups. These results support the proposition that these 5 peptides act as modulatory transmitters at feeding muscles.
No transport of neuropeptides from the cerebral ganglia to feeding muscles was observed, although myomodulin was specifically transported to the buccal ganglia. This suggests that this peptide may play an important role in the previously observed regulation of buccal ganglia activity by neurons in the cerebral ganglia.
The sequences of a number of neuropeptides of Aplysia have been determined. These peptides were generally chosen for study because of some specific property. For example, they may be synthesized in large quantities, either in very large individual neurons or in homogeneous cell groups. Such peptides are amenable to sequencing either through molecular genetic approaches or through conventional protein-sequencing procedures (Scheller et al., 1984) . However, many physiologically important neuropeptides may not fall into this category and therefore resist identification. More general approaches to peptide identification may reveal the existence of these peptides. The approach pursued in the present study was to identify neuropeptides that were labeled in central ganglia and transported by fast axonal transport to target muscles or ganglia.
The system chosen for this study consists of the buccal and cerebral ganglia and the muscles of the buccal mass. This comprises the consummatory part ofthe feeding apparatus ofAplysia and has been extensively studied at a number of levels. Neurons in the buccal ganglia generate the cyclic feeding motor output that drives biting and swallowing movements of muscles of the buccal mass (Gardner, 197 1; Kupfermann, 1974) . Neurons in the cerebral ganglia control the output of the buccal ganglia and modulate peripheral neuromuscular synapses .
Only peptides that contain methionine residues were studied. The results indicate that at least 5 methionine-containing peptides are transported from the buccal ganglia to the buccal muscle. These peptides were identified as myomodulin (Mm; Cropper et al., 1987b) , the 2 small cardioactive peptides (SCP,; Lloyd et al., 1987b; and SCP,; Morris et al., 1982) FMRFamide (Fa; Price and Greenberg, 1977) , and buccalin (Bn; Cropper et al., 1987~) . Each of the 5 peptides has been shown to modulate the efficacy of motor neurons in producing buccal muscle contractions. In muscle 15 (also termed the accessory radula closer muscle; ARC), the SCPs and Mm enhance, while Bn and Fa decrease, the amplitude of contractions produced by stimulation of motor neurons Weiss et al., 1986; Cropper et al., 1987b, c) . Both the nature of the modulation and the mechanisms underlying it vary for different buccal muscles. For example, the SCPs and Fa both enhance contractions of an extrinsic buccal muscle (Richmond et al., 1986) , and the SCPs have been shown to enhance contractions of another intrinsic muscle, but by a different mechanism than in 15 (D. P. Lotshaw and P. E. Lloyd, unpublished observations). Likewise, the transport of peptides to individual buccal muscles is not uniform. Different muscle groups receive different complements of peptides, and particular peptides are preferentially routed down particular nerve groups. These results should aid attempts both to understand the nature of modulation at individual buccal muscles and to identify neurons that synthesize the peptides.
The cerebral ganglia are the other central ganglia involved in generating aspects of feeding behavior (Kupfermann, 1974) . No measurable transport of peptides from the cerebral ganglia to buccal muscle was observed. This was somewhat surprising, as the major nonpeptidergic modulators of buccal muscles are serotonergic neurons in the cerebral ganglia . However, selective transport of Mm from the cerebral to the buccal ganglia was observed. This suggests that this peptide may have important central actions in the buccal ganglia. Transport experiments Labeled buccal ganglia. The cerebral-buccal connectives (CBCs) were cut and the cerebral ganglia discarded. The buccal nerves to be tested were protected from mechanical damage, while the other buccal nerves were severed. The ganglia-buccal mass complex was then placed in transport dishes containing 25% isotonic MgCl,: 75% artificial seawater (ASW: 460 mM NaCl, 10 GM KCl, 11 mM Call,, 55 mM MgCl,, 5 mM NaHCO,. DH 7.8). The transuort dishes were 150 ml in volume and had Sylgard bases into which polypropylene cylinders (12 mm diameter) were imbedded. The vertical cylinders were 2.5 cm high, filled with Sylgard for 1.8 cm, and had l-mm-wide vertical slits to allow passage of the nerves. The slits were occluded with Vaseline and the buccal ganglia pinned in the inner chamber at the top of the tube, with the nerves to be tested running through the Vaseline gap. Extra Vaseline was added to the gap to reseal it after placing the nerves through it. The solution in the large outside chamber was then changed to one with the following composition: 25% Aplysia blood, 75% ASW, 0.01% glucose, antibiotics (penicillin, 25 U/ml; streptomycin, 25 pg/ml), 0.01% 2-mercaptoethanol, and 100 PM cold methionine. The inside chamber was changed to the following solution: 50% Aplysia blood, 50% ASW, 0.0 1% glucose, antibiotics, 0.01% 2-mercaptoethanol, and 0.5 mCi/ml 35S-methionine (Amersham; stabilized with 0.1% 2-mercaptoethanol and 15 mM pyridine 3,4 dicarboxylic acid). After a 24 hr labeling period at 15°C the solutions in both inner and outer chambers were replaced with a chase solution consisting of ASW, 0.01% glucose, antibiotics, 0.01% 2-mercaptoethanol, and 1 mM methionine. All solutions were sterilized (0.2~pm-filtered) immediately prior to use. For the chase, the solution in the inner chamber was turned over -20 x , while the solution in the outer chamber was turned over twice over a period of 2 hr. Initially, chase periods of 24 or 48 hr were used; however, as no differences in transport were observed between the 2 durations, 24 hr chase periods were then routinely used. Radioactivity in the inner and outer chambers was monitored by liquid scintillation counting of small aliquots performed at the end of the label period and occasionally at the end of the chase periods as well. At the end of the label periods, the ratio of cpm/ml in the inner : outer chamber was 1953 f 717 (SE) for 18 preparations. In the 10 preparations for which measurements were made at the end of the chase periods, the ratio was 1197 + 566. In several experiments, 10 mM colchicine (Sigma) was added to both the inner and outer chambers throughout the label and chase periods.
Labeled cerebralganglia. Labeling was carried out exactly as described for the buccal ganglia, except that the CBCs were not cut, the cerebral ganglia were placed in the inner chamber, and the paired CBCs were run through the Vaseline gap to the buccal ganglia and buccal mass in the outer chamber. All buccal nerves except the esophageal and salivary nerves remained intact.
Buccal muscle designations Transport to individual muscles or muscle groups was analyzed. Muscles were identified using the original designations of Howells (1942) . In some cases, it was difficult to be certain of the assignments. For this reason, Figure 1 shows the muscle designations used in the present study, with the buccal mass pinned out in a manner similar to that used during the dissections.
Analyses of "S-methionine-labeled peptides in buccal ganglia and muscle At,the end of the chase periods, the remaining intact buccal nerves were cut, and the buccal mass removed and dissected in 25% isotonic MgCl,: 75% ASW. A longitudinal incision was made along the dorsal midline from the mouth opening to the esophageal opening, and the mass pinned SD I \ Figure I . Morphology of the buccal mass, showing the major muscles and muscle groups. A dorsal midline incision was placed between the paired extrinsic (E) muscles El and E3 and the spherical mass pinned flat with the ventral side facing upward. The original position of the buccal ganglia is indicated by the paired dashed circles. Muscle designations were modified from Howells (1942) . The thin intrinsic (I) muscle, 12, has been removed to expose the I5 and I6 muscles. The I3 muscle is covered with a thin muscle band termed 11 by Howells; however, this muscle is extensively interconnected with the much thicker 13, and was always dissected with I3 and the 2 muscles termed 13+. The designation 14+ was used for muscle I4 plus the connective tissue that remained after the removal of all the intrinsic muscles. Extrinsic muscles El, which run from just below I5 to the body wall near the mouth, are not shown in this diagram. A buccal mass from a 200 gm animal dissected as shown would be 2 x 3 cm. RS, radula sac; SD, salivary duct.
flat, with the radula sac facing upward in the middle of the preparation (see Fig. 1 ). Muscles were dissected from the innervated side and symmetrical muscles from the noninnervated side to act as controls. Muscles were blotted, weighed, and placed in homogenizers containing 0.02 M trifluoroacetic acid (TFA) and heated to 100°C for 10 min. The TFA solution was spiked with 1O-5 M Fa, SCP,, and SCP, (Peninsula). A tissue solution of 100 mg (wt/vol) tissue/l ml (wt/vol) 0.02 M TFA, with a minimum volume of 500 ~1 for tissue weights less than 50 ma, was used. After cooling, the tissue was homogenized, centrifuged at 10,000 x g for 10 min, and the supematant filtered on a Gelman LC 13 (0.45 pm) filter before HPLC. HPLC was carried out on a 0.46 x 22 cm Brownlee RP-300 C8 column with a guard column. The first mode of HPLC used 0.01 M TFA as a counterion, and a gradient from 95% H,O, 5% CH,CN to 47% H,O, 53% CH,CN in 20 min at a flow rate of 2 ml/min. Injections were 600 ~1 of 0.02 M TFA in H,O. Aliquots of the samples from this run were counted, and the remainder of the samples of interest dried and run on the same column with 0.0 1 M heptafluorobutyric acid (HFBA) replacing the TFA. The HFBA gradient was comprised of 3 linear segments with different slopes. The first segment was from 79% H,O, 2 1% CH,CN to 76% H,O, 24% CH,CN in 2 min, followed by a segment from 76% H,O, 24% CH,CN to 72% H,O, 28% CH,CN in 12 min. The final seament was from 72% H,O. 28% CHCN to 65% H,O. 35% CH,CN: The flow rate was 2 ml/t& and injections were 200 2 ofO.02 M HFBA in H,O. Entire samples from these runs were counted. Occasionally, a third HPLC method was used in addition to the previous 2 to confirm peptide identity. This method used the same column described above, but was carried out using 25 mM triethylamine acetate (TEAA) at pH 5.5 and a gradient from 90% H,O, 10% CH,CN to 55% H,O, 45% CH,CN in 18 min at a flow rate of 2 mumin.
Radiolabeled materials with very short retention times on the Brownlee column were analyzed using a more retentive 0.5 x 25 cm Isco C8 (5 pm Figure 2 . HPLC of extracts from buccal muscles indicates that the transport of neuropeptides from buccal ganglia to buccal muscles was completely blocked by colchicine. Transport with the lateral nerves intact on one side (INNERVATED) and cut on the other (CONTROL). The 2 preparations were run in parallel with all solutions in common, except that 10 mM colchicine was added to one of them. At the end of the experiment, the buccal mass was split at the midline and each half homogenized. The histograms are from a portion of the extracts equivalent to 50 mg of buccal muscle. Cold synthetic peptides were added before homogenization and the positions of the Fa and SCP, absorbance peaks are indicated by the dashed lines. The peak of label between Fa and SCP, is comprised of 3 peptides: Mm, SCP,, and Bn. Note that transport of methionine-containing neuropeptides only occurred when the preparation was innervated and colchicine was absent. In each experiment, the axes of the innervated and control sides were scaled to the total number of counts per minute collected in each run. There was always more label on the innervated sides, even in the presence of colchicine. This is especially true of label with short retention times.
Results
Fast axonal transport of methionine-labeled peptides from buccal ganglia to buccal muscle Labeled peptide peaks were observed only in muscle extracts from the side of the buccal mass in which the innervation from the ganglia remained intact (Fig. 2) . The 2 peaks of label corresponding to FMRFamide and SCP, are indicated in Figure 2 . The larger peak of label between Fa and SCP, is composed of Bn, Mm, and SCP, (see below). This indicates that the peptides were transported from the ganglia to the muscles via the intact nerves and were not synthesized by the muscles themselves. It also demonstrates that this transport was confined to the side of the buccal mass with intact nerves. Thus, the peptides were not transported across the midline of the buccal mass. The nature of the transport to individual muscles or muscle groups is described below. In the case of some of the more distal muscles, only 2 d were required for the synthesis, processing, and transport of the peptides over distances of several centimeters. It appears that this must occur via fast axonal transport. This was tested by determining the effects of 10 mM colchicine on peptide transport (Schwartz, 1979) . Figure 2 shows the results of such an experiment performed using the lateral nerve group because the longer length of these nerves allowed them to be positioned through the Vaseline gap with less stretching (see below). Significant transport of peptides was observed in each of 5 experiments with this nerve group. In contrast, no peptide transport was observed in 2 experiments with the same nerve group in the presence of colchicine. In the experiment shown in Figure 2 , peptide transport was analyzed from 3 preparations using all the same solutions, except that colchicine was added in 2 of the preparations. Colchicine did not appear to affect incorporation of methionine or processing to mature peptides. HPLC of buccal ganglia extracts at the end of the experiments indicated that there was more label in the Fa, Bn-Mm-SCP,, and SCP, peaks in the 2 colchicine-treated ganglia than in the untreated ganglia. The sensitivity to colchicine confirms that the peptides are transported from the ganglia to muscle by fast axonal transport.
D@ision of labeled methionine and glutathione Significantly more radioactivity was present in the unretained fractions from innervated muscles than noninnervated muscles (e.g., Fig. 2 ). This difference was not dependent on active transport because it was also observed in the presence of colchicine. The nature of the radioactivity in these samples was investigated by running them on a more retentive column. Most of the radioactivity was associated with unincorporated YS-methionine. Peaks with retention times similar to that of cysteine were also observed. A major peak that was predominantly in the innervated muscles was oxidized (disulfide-bridged) glutathione (GSSG). Labeled methionine, and perhaps cysteine, was found in higher concentrations, while labeled GSSG was found in considerably higher concentrations in the innervated side of the buccal mass. As both sides of the buccal mass were exposed to similar levels of radioactive methionine that had leaked through the Vaseline gap, the higher levels of these small molecules in the innervated side suggest that the molecules diffused down the nerves from the ganglia to buccal muscle. It also suggests that, over the period of these experiments (2-3 d), a significant proportion of % in methionine could be transferred to cysteine, either free or in GSSG. The rapid diffusion of small molecules down axons has been described previously in Aplysia (Koike and Nagata, 1979; Goldberg and Schwartz, 1980) . Transport of labeled peptides from buccal ganglia to buccal muscles via lateral nerves Lateral nerves are those nerves that exit the ganglion from the lateral margin, and include nerves 1, 2, and 3 (Gardner, 197 1) . Figure 3 summarizes the transport of identified peptides to individual muscles and muscle groups in 5 experiments. In Figure Ll 3, the radioactivity associated with each peptide was corrected to represent transport to an equivalent weight of muscle (50 mg) and for the number of methionine residues in each peptide. Mm and SCP, each have 2 methionine residues as compared to one in each of the other 3 peptides, so the radioactivity in their peaks was divided by 2. It was necessary to normalize these activity values in each experiment because preparations from different animals showed a wide range of total 35S-methionine incorporation, presumably stemming from differences in endogenous methionine pools or other metabolic factors. For each preparation, the corrected specific activity of each peptide to each muscle was totaled, and the specific activity of any single peptide transported to a muscle was then given as the percentage of this total. When normalized in this fashion, the specific activity of peptides transported to particular muscles was quite reproducible (i.e., Figs. 3, 6 ). The pattern of transported peptides is different for each muscle (Fig. 3) . Fa was transported primarily to 14+ and 13+, in low levels to 16, and in very low levels to 15. Muscle 15 is also referred to as the accessory radula retractor muscle . Bn was transported in amounts comparable to those of the other peptides only to 15. With the exception of 14+, the SCPs and Mm were transported to each of the muscles in similar amounts. The low specific activity for peptide transport to 14+ may reflect the fact that this sample included a significant proportion of connective tissue, as well as the 14 muscle group. Finally, SCP, was found in amounts very similar to those of SCP, in every muscle. This result was expected from the observations that identified neurons synthesize the 2 SCPs in equimolar concentrations, and that the SCP precursor contains single copies of each SCP Lloyd et al., 1987b) . The results of an experiment in which transport via the lateral nerves to muscles 13+ and 15+ was analyzed show the procedure used to quantify transport (Figs. 4,5) . As in the cumulative data, this 13+ muscle receives comparable levels of Fa, Mm, and the SCPs and much lower amounts of Bn, while this 15 muscle receives comparable amounts of Mm, the SCPs, and Bn, -!- Figure 4 . Transport of methionine-labeled peptides from buccal ganglia to muscle 13+ via the lateral nerves. A, HPLC with TFA as counterion of extracts from the innervated and noninnervated (control) 13 + muscles from the same buccal mass. In this experiment, the axes of the innervated and control sides were scaled to the total number of counts per minute collected in each run. B, Aliquots of the samples marked l-3 in A were run on HPLC with HFBA as counterion. Retention times of synthetic peptides are indicated by the dashed lines. Sample 1 was primarily Fa; 2 was Mm, SCP,, and a trace of Bn, 3 was nearly all SCP,. Note that the counts per minute have not been normalized for methionine content: Mm and SCP, have 2 methionine residues to one for the other peptides. but nearly no Fa. In both Figures 4 and 5 , the activity in the peptide peaks was not corrected for the number of methionine residues per peptide. Note that there were no peptide peaks in the control (noninnervated) contralateral muscles.
As mentioned above, these comparisons are based on analyses of 50 mg of tissue or, in the case of smaller muscles, are corrected to the equivalent of 50 mg. To compare total transport, the size of the muscle was taken into account. Normalizing the weight of the smallest muscle, 15, to 1.0:12 was 1.5; 13+ was 15.2; 16 was 15.3; and I4+ was 23.8-fold larger. Using the normalized weights and the normalized specific transport values (see Fig.  3 ), the percentages of total peptide transport via the lateral nerves were as follows: Fa, 30.7%; SCPA, 24.2%; SCP,, 2 1.0%; Mm, . Transport of methionine-labeled peptides from buccal ganglia to muscle 15 via the lateral nerves. A, HPLC with TFA as counterion of extracts from the innervated and noninnervated (control) I5 muscles from the same buccal mass. In this experiment, the axes of the innervated and control sides were scaled to the total number of counts ner minute collected in each run. B, Aliquots of the samples marked 1 and 2 in A were run on HPLC with HFBA as counterion. Retention times of synthetic peptides are indicated by the dashed lines. Sample I was SCP,, Mm, and Bn; 2 was nearly all SCP,. Note that the counts per minute have not been normalized for methionine content: Mm and SCP, have 2 methionine residues to one for the other peptides.
20.5%; and Bn, 3.6%. These values reflect the fact that the muscle groups in which Fa was the predominant transported peptide, 13+ and 14+, are very large, whereas 15, the only muscle with transport of Bn comparable to that of the other peptides, is very small. Other small intrinsic (not identified in Fig. 1 ) and extrinsic (E2 and E3 in Fig. 1 ) muscles were also analyzed. No transported peptides were observed; however, many of these muscles weighed only a milligram or less, so moderate levels of transport would not have been detected. In addition, in one of the 5 experiments, Fa, Mm, and the SCPs, but not Bn, were transported to muscle 12. In the other 4 experiments, no transported peptides were observed in this muscle. We have no explanation for why transport was observed in only a single experiment.
Transport of labeled peptides from buccal ganglia to buccal muscle via radula nerves
The radula nerve leaves the buccal ganglia from the commissure between the 2 ganglia and immediately enters the muscles of the buccal mass, where it runs for a few millimeters before dividing into 2 major branches. Each branch innervates one side of the buccal mass. To obtain a sufficient length to run through the Vaseline gap, the nerve was dissected free of the muscle up to its bifurcation, and one branch was severed to provide the noninnervated control side. Even so, the length of free nerve was considerably shorter than that available for the lateral nerves and, consequently, more tension was placed on the radula nerve. Significant transport was observed in 3 of 4 experiments. Presumably, in the one unsuccessful experiment, transport was disrupted by undue stretching of the radula nerve. The cumulative data from the 3 experiments in which significant transport was observed are shown in Figure 6 . Again, when normalized as described above, the nature of the peptide transport was quite reproducible between preparations. The pattern was very different from that observed for the lateral nerves. Peptides were only transported to 14+ and 16. Using the normalized weights and the normalized specific transport values, the percentages of total peptide transport via the radula nerve were as follows: Mm, 83.9%; SCP,, 6.1%; SCP,, 5.1%; Bn 3.1%; and Fa, 1.7%. Thus, Fa, which was transported in the largest quantities by the lateral nerves, was transported in the lowest quantities in the radula nerves.
Quantitative comparison of overall peptide transport between lateral and radula nerves A quantitative comparison of transport via the lateral and radula nerves is complicated by the variability we observed within each nerve group. However, a few generalizations can be made. First, the peptide transported in the greatest quantity was certainly Mm to 16 via the radula nerve. In 3 experiments, total Mm transport to the whole 16 muscle was 23,805 f 12,505 cpm (SE). In comparison, Mm transport to 16 via the lateral nerves was 4061 f 1844 cpm (n = 5) and the predominant peptide transported via the lateral nerves was Fa to 13+, at 4987 + 2764 cpm (n = 5). When the number of methionine residues are taken into account, about twice as much Mm was transported to 16 via the radula nerves as was Fa to 13+ via the lateral nerves. The difference is actually more dramatic than Transport of Peptides i n Aplysia this, since this is a comparison of a single radula nerve with 3 lateral nerves.
Transport of labeled peptides from cerebral ganglia The other central ganglia that play a role in the consummatory (biting) phase of feeding behavior in Aplysia are the cerebral ganglia (e.g., Kupfermann, 1974) . In addition, neurons in the cerebral ganglia provide the major serotonergic modulatory innervation of buccal muscles . Therefore, peptide transport from the cerebral ganglia to the buccal ganglia and buccal muscles was also analyzed. No transport of labeled peptides to any of the buccal muscles was observed in 3 experiments. However, in each of these experiments, significant transport of Mm to the buccal ganglia was observed (Fig. 7) . Very small amounts of Bn and Fa, and no measurable SCP, or SCP,, were observed to be transported from the cerebral to buccal ganglia. There are several reasons to believe that the absence of transport from the cerebral ganglia to buccal muscle was not simply a reflection of the increased transport distance. First, significant transport of neuropeptides from the abdominal ganglia to the cerebral ganglia has been consistently observed within the same time periods used in this study (P. E. Lloyd, unpublished observations). The distance from the abdominal to cerebral ganglia is severalfold greater than that from the cerebral ganglia to the most distant buccal muscles. Second, substantial transport of Mm to the buccal ganglia was observed in each of 3 experiments. The number of counts of Mm in the buccal ganglia was 65 13 f 4074 (SE). Transport of even a few percent of this to buccal muscles would have been noted. Finally, in 2 experiments, the lateral and radula nerves that lead from the buccal ganglia to the muscles were pooled, extracted, and analyzed by HPLC. Again, no labeled peptides were detected. The fact that Mm is transported to the buccal ganglia and no further suggests that this peptide is likely to have important central actions in these ganglia.
Discussion
We have identified neuropeptides that were transported by fast axonal transport from the buccal ganglia to buccal muscles. Selective fast axonal transport of conventional neurotransmitters has been previously observed in Aplysia (reviewed in Schwartz, 1979) . The major transported peptides were Fa, Bn, Mm, and the 2 SCPs. These results support the proposition that each of these peptides functions as a neuromodulator at the synapses between buccal motor neurons at their target muscles. Each of the peptides has previously been shown to be present in the buccal ganglia and buccal muscle of Aplysia, and to modulate the efficacy of neuromuscular synaptic transmission at buccal muscle Richmond et al., 1986; Cropper et al., 1987a-c; and D. P. Lotshaw and P. E. Lloyd, unpublished observations) . Bn and Mm were identified and sequenced very recently, so there is little additional information concerning their roles in Aplysia nervous tissue. There is evidence that the SCPs play major roles in the regulation of all aspects of feeding behavior (Lloyd, 1986) . These peptides are found in 1 O-fold higher concentrations in the buccal ganglia than in other regions of the central nervous system . They appear to be involved in the control of the central pattern generator for feeding in the buccal ganglia of Aplysia (Sossin et al., 1987) and other gastropods (Murphy et al., 1985; Willows et al., 1988 Figure 7 . Transport of methionine-labeled peptides from cerebral ganglia to buccal ganglia via the cerebrobuccal connectives (CBCs) . A, HPLC with TFA as counterion of extracts from the buccal ganglia. In this experiment, both CBCs were left intact, so there is no control; however, the profile of incorporation, when the buccal ganglia themselves are incubated with labeled methionine, is very different-from that seen here (Lloyd et al., 1987b) . B, In the upper projle, aliquots of samples 1 in A were run on HPLC with HFBA as counterion. Retention times of synthetic peptides are indicated by the dashed lines. Sample 1 was nearly all Mm, with a trace of Bn and no SCP,. In the lower profile, aliquots of samples 1 in A were run on HPLC using TEAA buffer at pH 5.5. Note that this buffer reverses the relative retention times of Mm and Bn, but that the labeled peak continues to coelute precisely with Mm. The combination of these 3 procedures confirms that Mm is the predominant methionine-containing peptide transported from the cerebral ganglia to the buccal ganglia.
1988; Lloyd et al., 1988) . These neurons contain the SCPs in dense-core vesicles and release these peptides in an activity-and calcium-dependent manner, indicating that the SCPs are indeed transmitters Reed et al., 1988) . FMRFamide has also been localized to dense-core vesicles (Kreiner et al., 1986) , and FMRFamide or FMRFamide-like substances have been implicated in the modulation of the contractile activity of gill muscles in Aplysia . Finally, Fa and the SCPs have been shown to modulate central synapses between sensory and motor neurons in the abdominal ganglia of Aplysia (Abrams et al., 1984; Belardetti et al., 1987) . Several conclusions can be drawn from the present data. Mm was the predominant peptide transported to buccal muscle, which occurred primarily via the radula nerves. The overall quantity of transport to the whole buccal mass was similar for Fa and the SCPs, but Bn was transported at significantly lower levels.
